| Delaware Back Pain & Sports Rehabilitation Centers | |
|
2150 New Castle Ave, New Castle, DE 19720-2009 | |
| (302) 529-8783 | |
| (302) 529-1586 |
| Full Name | Delaware Back Pain & Sports Rehabilitation Centers |
|---|---|
| Type | Facility |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 2150 New Castle Ave, New Castle, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548582752 | NPI | - | NPPES |
| 14704 | Medicaid | DE | |
| 2272852000 | Other | DE | AMERIHEALTH |
| CC5686 | Other | DE | RAILROAD MEDICARE |
| 386606954 | Other | DE | BC/BS |
| 5707129 | Other | DE | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | (* (Not Available)) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Delaware Back Pain & Sports Rehabilitation Centers 2006 Foulk Rd, Suite B, Wilmington, DE 19810-3644 Ph: (302) 529-8783 | Delaware Back Pain & Sports Rehabilitation Centers 2150 New Castle Ave, New Castle, DE 19720-2009 Ph: (302) 529-8783 |
News Archive
A woman lies in her hospital bed. Her heart rate is elevated, she has a slight fever and an elevated white blood cell count.
Cardio3 BioSciences, a leader in the discovery and development of regenerative, protective and reconstructive therapies, announces today it has received authorization from Swissmedic, the Swiss agency for the authorisation and supervision of therapeutic products, to begin its Congestive Heart failure Cardiopoietic Regenerative Therapy (CHART-1) European Phase III trial for C-Cure in Switzerland.
Brand-name prescription drug makers in fiscal year 2007 reached 14 agreements with generic drug makers to delay market entry of generic medications, according to a report released on Wednesday by the Federal Trade Commission, Reuters reports (Bartz, Reuters, 5/23).
When investigating cancer cells, researchers discovered numerous peculiarities: Particular RNA molecules are present in large numbers, particular genes are overactive. Do these characteristics have a relation to cancer? Do they promote cell growth? Do they inactivate growth brakes or are they just a whim of nature?
The newer high-sensitivity troponin test discovers smaller amounts of heart-specific proteins, troponins, than the older troponin test and thus identifies more myocardial infarction patients than before.
› Verified 8 days ago